Virtual Histology Findings and Effects of Varying Doses of Atorvastatin on Coronary Plaque Volume and Composition in Statin-Naive Patients
スポンサーリンク
概要
- 論文の詳細を見る
Background: While statin induces plaque regression, its effects, particularly with different doses on plaque virtual histology composition, remain unknown. Methods and Results: In this prospective, randomized, double-blinded study, 40 consecutive statin-naive patients with stable angina requiring percutaneous coronary intervention (PCI) were randomized to 2 arms (20 patients each) receiving 6 months of atorvastatin 10mg or 40mg daily. The primary end-point was (VH-IVUS) changes from baseline to 6 months, as assessed by a core laboratory. Fifty-four VH-IVUS lesions were analyzed from the 10mg group and 57 from the 40mg group. Overall, plaque volume was reduced by 4.28% (–5.10±14.93mm3, P<0.001), absolute VH-IVUS fibrous volume by 10.54% (–4.87±10.74mm3, P<0.001), and relative percentage fibrous component by 3.29±7.84% (P<0.001), while relative percentage dense calcium increased by 1.50±3.08% (P<0.001), and necrotic core by 3.19±7.82% (P<0.001). Beneficial changes were more substantial in the higher dose (40mg) group, with significantly more percentage plaque volume regression (–1.50±3.85% vs. 0.38±4.05% increase in the 10mg group, P=0.014), less relative percentage necrotic core expansion (1.68±7.57% vs. 4.78±7.82% in the 10mg group, P=0.037), and without occurrence of major adverse cardiac events (vs. 6 patients in the 10mg group, P=0.020). Conclusions: In statin-naive patients requiring PCI, 6 months of atorvastatin induced a significant percentage of plaque volume reduction and substantial modification of VH-IVUS composition. In addition, these effects appeared to vary with different doses of atorvastatin, showing significantly better limitation of relative percentage necrotic core expansion at a higher dose. (Circ J 2012; 76: 2662–2672)
著者
-
Lee Stephen
Division Of Cardiology Department Of Medicine Queen Mary Hospital
-
Tse Hung-fat
Division Of Cardiology Department Of Medicine Queen Mary Hospital
-
HAU William
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
-
LAM Yui
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
-
WONG Michael
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
-
KONG Shun
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
-
CHAN Kelvin
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
-
CHAN Pak-Hei
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
-
LAM Simon
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
-
TAM Frankie
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
-
CHAN Carmen
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
-
CHAN Raymond
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
-
LEE Stephen
Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital
関連論文
- OE-174 Prospective Study of Isoflavone Intake on the Risk of Stroke Recurrence : Clinical Implications beyond Vascular Function(OE30,Preventive Medicine/Epidemiology/Education (H),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japan
- Left Ventricular Mechanical Dyssynchrony Impairs Exercise Capacity in Patients With Coronary Artery Disease With Preserved Left Ventricular Systolic Function and a QRS Duration≦120ms
- Virtual Histology Findings and Effects of Varying Doses of Atorvastatin on Coronary Plaque Volume and Composition in Statin-Naive Patients
- Optimizing heart failure therapy with implantable sensors
- Virtual Histology Findings and Effects of Varying Doses of Atorvastatin on Coronary Plaque Volume and Composition in Statin-Naive Patients : The VENUS Study